The review has paused over 50 applications from CBD companies hoping to acquire a “novel food” status for their products.
To help decide what to do with the impounded products, state authorities are welcoming input from the public until July 15.
Product testing conducted by the US Food and Drug Administration (FDA) has found that many CBD-infused products on sale in the United States are mislabeled, containing vastly differing amounts of CBD than advertised on the product packaging.
The new rule was initially meant to take effect on April 1, but delays were made amid the coronavirus pandemic.
With a steady increase of research into cannabinoids, and with changes to legalization and regulation, the future of the cannabis beverage industry will have to overcome considerable challenges to keep up with new consumer demands.
The cannabis and hemp testing company Kaycha Labs has become the first business in Florida to be awarded the state Department of Health’s certified marijuana testing laboratory status.
New sample collectors will be allowed to collect samples of cannabis and cannabis products for testing on behalf of the state’s cannabis testing facilities.
How can cannabis labs leverage powerful analytical technologies to ensure novel products like cannabis-based beverages meet consumer safety and quality demands?